Clinical Trials Browser

Neoplasms × Immunotherapy, Adoptive × Plasma cell × Clear all

NCT07612787 2026-05-29

BELAMI

Phase 2 Not yet recruiting

Multiple Myeloma, Neoplasms, Recurrence